“…The so-called small-for-size syndrome (SFS) seems to be present in most series worldwide. This syndrome may have different aspects in its etiology: those related to the graft, such as size, actual functional mass, [3][4][5] or anatomic variability (presence of a significant branch, tributary of the middle hepatic vein) 6,7 ; those related to the recipient, such as metabolic status (diabetes, impaired renal function, etc), advanced disease stage (Child-Pugh score Ͼ9), and severity of portal hypertension 8 ; and finally, those related to the surgical technique, such as preservation of the middle hepatic vein with the graft (right liver), type of the right hepatic vein anastomosis with the vena cava, or the anastomosis of any significant branch (larger than 8 mm in diameter) also with the vena cava. [9][10] The relationship between the graft mass and the recipient's weight is very important in trying to prevent the incidence of the SFS.…”